🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
This partially randomized phase Ib/II trial studies the side effects and be...
Status
Terminated
Location
University of Alabama, Birmingham
Start Date
2015-06
Trial ID
NCT02457910
Treatments Being Tested
This research study is evaluating a drug called enzalutamide in combination...
Status
Unknown
Location
Hospital Ramón y Cajal
Start Date
2017-12-27
Trial ID
NCT03196388
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and phar...
Status
Completed
Location
ATTN-Research Pharmacist
Start Date
2012-04-30
Trial ID
NCT01597193
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641
This randomized phase III trial studies enzalutamide to see how well it wor...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-22
Trial ID
NCT01949337
Treatments Being Tested
This Phase I, open-label, dose-finding, multicenter study is designed to de...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-13
Trial ID
NCT02215096
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested
The purpose of this study is to find out whether talazoparib in combination...
Status
Recruiting
Location
City of Hope
Start Date
2026-05-04
Trial ID
NCT06844383
Treatments Being Tested
This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Status
Completed
Location
The Mayo Clinic - Phoenix
Start Date
2017-03-06
Trial ID
NCT03009981
Treatments Being Tested